P5-PARK – A new target for parkinsonism based on a type 5 P-type ATPase
Scientists at the University of Cologne, Germany, have linked successfully a trans-membrane ATPase to the hereditary parkinsonism Kufor Rakeb syndrome PARK9. Loss of function mutations of P5-PARK were deemed to be causative for this autosomal recessive form of early-onset parkinsonism with pyramidal degeneration and dementia.
Analysis of P5-PARK sequence and/or expression will provide tools for diagnosis and therapy of hereditary neurodegenerative diseases like parkinsonism and dementia.
Further Information: PDF
PROvendis GmbH
Phone: +49 (0)208/94105 0
Contact
Dipl.-Ing. Alfred Schillert
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Silicon Carbide Innovation Alliance to drive industrial-scale semiconductor work
Known for its ability to withstand extreme environments and high voltages, silicon carbide (SiC) is a semiconducting material made up of silicon and carbon atoms arranged into crystals that is…
New SPECT/CT technique shows impressive biomarker identification
…offers increased access for prostate cancer patients. A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more…
How 3D printers can give robots a soft touch
Soft skin coverings and touch sensors have emerged as a promising feature for robots that are both safer and more intuitive for human interaction, but they are expensive and difficult…